Drugs / Ricrolin+
last change Jun 2019 re-read 3 minutes ago

Ricrolin+

Developed for
corneal ectasia · keratoconus
Investigated by
Icahn School of Medicine at Mount Sinai

Trials 1

20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT03080077 Jun 2016 → Jun 2019 corneal ectasia, keratoconus Icahn School of Medicine at Mount Sinai Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Ricrolin+ ClinicalTrials.gov intervention name — accepted as the source's own label NCT03080077 ↗